Sonoma Pharmaceuticals, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for SNOA, updated each market day.
SNOA AI Sentiment
AI predicts Sonoma Pharmaceuticals, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Sonoma Pharmaceuticals, Inc. Common Stock
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
Sector
Exchange
Market Cap
$4,170,777
Cap Tier
Employees
168
Headquarters
BOULDER, CO
Listed Since
Jan. 25, 2007
Website
SNOA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
SNOA Volatility
Sonoma Pharmaceuticals, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
